---
title: "Supernus Pharmaceuticals to Participate in September Investor Conferences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297829814.md"
description: "Supernus Pharmaceuticals, Inc., a biopharmaceutical company based in Rockville, Maryland, revealed on September 2, 2026, that they will take part in upcoming investor conferences in September. The company, listed on Nasdaq as SUPN, specializes in creating and distributing treatments for central nervous system (CNS) disorders. This move emphasizes their commitment to engaging with investors and stakeholders."
datetime: "2026-09-02T20:32:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297829814.md)
  - [en](https://longbridge.com/en/news/297829814.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297829814.md)
generator: "portal-rs"
---

# Supernus Pharmaceuticals to Participate in September Investor Conferences

Supernus Pharmaceuticals, Inc., a biopharmaceutical company based in Rockville, Maryland, revealed on September 2, 2026, that they will take part in upcoming investor conferences in September. The company, listed on Nasdaq as SUPN, specializes in creating and distributing treatments for central nervous system (CNS) disorders. This move emphasizes their commitment to engaging with investors and stakeholders.

### Related Stocks

- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)

## Related News & Research

- [Supernus Pharmaceuticals management attends Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297827223.md)
- [Great Lakes Advisors LLC Acquires Shares of 29,800 Supernus Pharmaceuticals, Inc. $SUPN](https://longbridge.com/en/news/296676820.md)
- [If I could invest $500 in just 1 ETF in September, here's what I'd buy](https://longbridge.com/en/news/298347627.md)
- [There Are Only a Handful of S&P 500 Stocks That Yield Over 5%. Here's My Top Pick to Buy in September.](https://longbridge.com/en/news/298194112.md)
- [Diversified Royalty announces $0.02375 September dividend per share](https://longbridge.com/en/news/297959336.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**